DCVAX Trademark

Trademark Overview


On Tuesday, June 3, 2014, a trademark application was filed for DCVAX with the United States Patent and Trademark Office. The USPTO has given the DCVAX trademark a serial number of 86298423. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 14, 2024. This trademark is owned by Northwest Biotherapeutics, Inc.. The DCVAX trademark is filed in the Pharmaceutical Products category with the following description:

Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; Derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned med...
dcvax

General Information


Serial Number86298423
Word MarkDCVAX
Filing DateTuesday, June 3, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 14, 2024
Registration Number5332321
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements


Goods and ServicesImmune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; Derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for medical or veterinary use; Vaccines
Pseudo MarkDC VAX; DC VACCINES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 16, 2014
Primary Code005
First Use Anywhere DateWednesday, March 6, 2002
First Use In Commerce DateWednesday, March 6, 2002

Trademark Owner History


Party NameNorthwest Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Party NameNorthwest Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Party NameNorthwest Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Trademark Events


Event DateEvent Description
Tuesday, September 16, 2014ASSIGNED TO EXAMINER
Friday, June 6, 2014NEW APPLICATION ENTERED
Monday, June 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 17, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, September 17, 2014SUSPENSION LETTER WRITTEN
Wednesday, September 17, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, September 17, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 23, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 25, 2015ASSIGNED TO LIE
Friday, September 25, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 28, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 28, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 28, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 21, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, March 6, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 10, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 14, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 14, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 14, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED